R&D Pipeline for New Medicine
R&D_Pipeline
(
US,
China )
| Project code | Indication | Discovery | Preclinical | Phase1 | Phase2 | Phase3 | Partners | |
|---|---|---|---|---|---|---|---|---|
| Immunology | HL036 (tanfanercept) | Dry eye disease (DED) |
|
|
|
|
|
(China) |
| HL161 (batoclimab) | Myasthenia gravis (MG) |
|
|
|
|
|
(US/EU) (China) |
|
| Thyroid eye disease (TED) |
|
|
|
|
(US/EU) (China) |
|||
| Warm autoimmune hemolytic anemia (WAIHA) |
|
|
|
(US/EU) |
||||
| Neuromyelitis optica (NMOSD) |
|
|
|
|
(China) |
|||
| Chronic inflammatory demyelinating polyneuropathy (CIDP) |
|
|
|
(US/EU) (China) |
||||
| Grave's disease (GD) |
|
|
|
(US/EU) |
||||
| Immune thrombocytopenia (ITP) |
|
|
|
|
(China) |
|||
| Pemphigus vulgaris (PV) |
|
|
|
(China) |
||||
| HL189 (tanfanercept) | Non-Infectious uveitis(NIU) |
|
|
|||||
| Oncology | HL186 | Immuno-oncology |
|
|
||||
| HL187 | Immuno-oncology |
|
|
|